Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utidelone Combined With Capecitabine in Active Brain Metastasis of Triple-negative Advanced Breast Cancer
NCT06598046Phase 2Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2028
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of utidelone in breast cancer, sponsored by Henan Cancer Hospital. Started Jun 2024; status: recruiting.
02
Drugs
utidelone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06598046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06598046.